Shockwave Medical (SWAV) Tops Q3 EPS by 39c, Raises FY Revenue Outlook

Shockwave Medical (NASDAQ: SWAV) reported Q3 EPS of $0.92, $0.39 better than the analyst estimate of $0.53. Revenue for the quarter came in at $131.3 million versus the consensus estimate of $123.97 million.

GUIDANCE:

Shockwave Medical sees Q4 2022 revenue of $483-488 million, versus the consensus of $475.94 million.

For earnings history and earnings-related data on Shockwave Medical (SWAV) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance